当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 现金流量表

君实生物-U

(688180)

  

流通市值:256.67亿  总市值:343.84亿
流通股本:7.66亿   总股本:10.27亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,559,876,252.73836,531,206.522,711,136,293.872,025,755,430.01
  收到的税费返还32,819,697.13-35,324,766.6435,251,559.56
  收到其他与经营活动有关的现金54,879,628.394,634,382.4194,822,421.5378,605,078.72
  经营活动现金流入小计1,647,575,578.25841,165,588.932,841,283,482.042,139,612,068.29
  购买商品、接受劳务支付的现金790,403,738.4394,081,798.571,787,943,409.491,329,838,706.42
  支付给职工以及为职工支付的现金730,805,430.16314,545,623.441,206,151,226.86926,704,264.05
  支付的各项税费79,334,795.3929,296,607.61111,872,785.9189,588,618.43
  支付其他与经营活动有关的现金115,593,835.1745,392,324.32254,883,792.1136,890,747.56
  经营活动现金流出小计1,716,137,799.12783,316,353.943,360,851,214.362,483,022,336.46
  经营活动产生的现金流量净额-68,562,220.8757,849,234.99-519,567,732.32-343,410,268.17
二、投资活动产生的现金流量:
  收回投资收到的现金2,063,500,000651,000,0002,270,000,0001,680,000,000
  取得投资收益收到的现金7,073,303.092,550,493.159,538,557.037,390,735.1
  处置固定资产、无形资产和其他长期资产收回的现金净额138,757-13,016,642.58,016,042.5
  收到的其他与投资活动有关的现金16,169,814.747,392,058.7832,707,349.6723,242,429.1
  投资活动现金流入小计2,086,881,874.83660,942,551.932,325,262,549.21,718,649,206.7
  购建固定资产、无形资产和其他长期资产支付的现金337,187,490.98251,907,576.74768,298,592.7509,553,908.28
  投资支付的现金3,179,148,736.73950,400,0023,116,756,642.412,096,966,746.75
  支付其他与投资活动有关的现金8,911,066.44-20,918,197.3120,918,197.31
  投资活动现金流出小计3,525,247,294.151,202,307,578.743,905,973,432.422,627,438,852.34
  投资活动产生的现金流量净额-1,438,365,419.32-541,365,026.81-1,580,710,883.22-908,789,645.64
三、筹资活动产生的现金流量:
  吸收投资收到的现金--940,183,277.12940,583,277.12
  其中:子公司吸收少数股东投资收到的现金--600,0001,000,000
  取得借款收到的现金1,542,421,530.951,421,047,188.743,578,540,240.082,502,424,857.04
  发行债券收到的现金1,000,000,0001,000,000,000--
  收到其他与筹资活动有关的现金1,668,002.54-246,000,00090,000,000
  筹资活动现金流入小计2,544,089,533.492,421,047,188.744,764,723,517.23,533,008,134.16
  偿还债务支付的现金790,760,650.61582,300,0002,397,592,040.591,886,053,666.68
  分配股利、利润或偿付利息支付的现金60,485,075.2728,011,611.3594,328,861.0470,493,903.92
  支付其他与筹资活动有关的现金48,430,341.5618,386,914.9843,496,873.1633,889,245.7
  筹资活动现金流出小计899,676,067.44628,698,526.332,535,417,774.791,990,436,816.3
  筹资活动产生的现金流量净额1,644,413,466.051,792,348,662.412,229,305,742.411,542,571,317.86
四、汇率变动对现金及现金等价物的影响-25,542,687.74-12,144,143-21,706,525.95-7,377,820.48
五、现金及现金等价物净增加额111,943,138.121,296,688,727.59107,320,600.92282,993,583.57
  加:期初现金及现金等价物余额2,593,999,709.742,593,999,709.742,486,679,108.822,486,679,108.82
  期末现金及现金等价物余额2,705,942,847.863,890,688,437.332,593,999,709.742,769,672,692.39
补充资料:
  净利润-40,823,699.21--1,009,393,410.45-
  资产减值准备4,109,940.68-98,098,076.08-
  固定资产和投资性房地产折旧120,761,561.07-243,515,843.96-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧120,761,561.07-243,515,843.96-
  无形资产摊销17,897,176.61-35,257,393.82-
  长期待摊费用摊销3,134,962.73-5,444,464.77-
  处置固定资产、无形资产和其他长期资产的损失-48,467,787.3--35,259,378.72-
  固定资产报废损失237,088.29-176,171.61-
  公允价值变动损失-25,736,499.34--57,210,254.39-
  财务费用73,849,509.17-67,894,071.23-
  投资损失-108,091,473.65-106,416,782.78-
  递延所得税1,972,853.59--1,263,252.01-
  其中:递延所得税资产减少1,972,853.59--1,263,252.01-
  存货的减少-57,213,889.81--53,110,382.81-
  经营性应收项目的减少-282,173,865.23-105,159,472.72-
  经营性应付项目的增加2,753,318.45--128,073,222.72-
  其他122,614,377.5-72,098,306.74-
  现金的期末余额2,705,942,847.86-2,593,999,709.74-
  减:现金的期初余额2,593,999,709.74-2,486,679,108.82-
  现金及现金等价物的净增加额111,943,138.12-107,320,600.92-
公告日期2026-08-272026-04-282026-03-142025-10-29
审计意见(境内)标准无保留意见
TOP↑